CLASS III Drug recall · Reported 23 Aug 2017 · FDA Enforcement Report

Voriconazole Tablets, 200 mg cartons Dose recalled by AVKARE

AVKARE is recalling Voriconazole Tablets, 200 mg cartons Dose, distributed nationwide in the US. The recall was initiated on 19 Jul 2017 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot #: 16933, Exp 07/2018; 17054, Exp 08/2018
Quantity recalled1172 cartons (23440 tablets)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1094-2017
FDA event ID
77800
Recalling firm
AVKARE, Pulaski, TN
Classification
Class III
Status
Terminated
Recall initiated
19 Jul 2017
FDA classified
15 Aug 2017
Reported
23 Aug 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

19 Jul 2017Recall initiated by company
15 Aug 2017Classified by FDA+27 days
23 Aug 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed impurities/degradation specifications: Out of specification for a related compound C.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Voriconazole Tablets, 200 mg, 20-count cartons (4 x 5) Unit Dose, Rx only, Manufactured for: AvKARE, Inc. Pulaski, TN 38478, NDC 50268-804-12

Where it was distributed

Nationwide

Nationwide

Questions about this recall

Is Voriconazole Tablets, 200 mg cartons Dose recalled?

Yes. AVKARE recalled Voriconazole Tablets, 200 mg cartons Dose on 19 Jul 2017. The recall is Class III and its status is Terminated. Recall number D-1094-2017.

Why was it recalled?

Failed impurities/degradation specifications: Out of specification for a related compound C.

Which lots are affected?

Lot #: 16933, Exp 07/2018; 17054, Exp 08/2018

Where was it sold?

Nationwide

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from AVKARE

All 57
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIAmantadine HCl, Capsules, UPS, 100 mg dose recalled by AvKAREAmantadine HclAvKAREPotency & AssayNationwide
DrugCLASS IIRosuvastatin Tablets, USP, 10 mg recalled by AvKARERosuvastatinAvKAREPotency & AssayNationwide
DrugCLASS IINorgestimate and Ethinyl Estradiol Tablets recalled by AvKARENorgestimate And Ethinyl EstradiolAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 100 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide
DrugCLASS IIchloroproMAZINE Hydrochloride Tablets, USP, 50 mg unit dose recalledChlorpromazine HydrochlorideAvKAREOtherNationwide

Other Voriconazole recalls

All 6